AS

Abdul Salam Ameerali

Active Director Director DIN 08091822
DIN 08091822 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 12 active board seats
Total affiliations 12 Since May 2018
Shareholding value •••• Premium profile

About Abdul Salam Ameerali

Data last updated:

Abdul Salam Ameerali is a Director at Hindustan Pharma Distributors Private Limited (since 2021), Director at Sri Sainatha Multispeciality Hospitals Private Limited (since 2021) and Director at Dm Med City Hospitals (India) Private Limited (since 2021), and holds 9 more current directorships. The companies operate in Pharma, Healthcare and Infrastructure and Utilities. The 8 current companies with reported revenue have a combined latest revenue of ₹307 Cr; the largest is Hindustan Pharma Distributors Private Limited at ₹135 Cr (FY 2025).

DIN 08091822
Primary Designation Director
Industry Pharma
First Appointment 21 May 2018
Oldest Company Age 19 yrs
Largest company Hindustan Pharma Distributors Private Limited · ₹135 Cr (FY 2025)
Combined revenue ₹307 Cr across 8 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Oct 20212021₹135 Cr (FY 2025)Active
Director08 Nov 20212007₹74.74 Cr (FY 2025)Active
Director10 Sep 20212009₹55.22 Cr (FY 2023)Active
Designated Partner03 Sep 20212019₹39.44 Cr (FY 2021)Active
Director02 Sep 20212008₹71.1 Lakh (FY 2023)Active
Director21 May 20182010₹58.1 Lakh (FY 2022)Active
Director10 Sep 20212021₹53 Lakh (FY 2024)Active
Director10 Sep 20212010₹16.1 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Ambady Infrastructure Private Limited
Emed Human Resources India Private Limited
Sri Sainatha Multispeciality Hospitals Private Limited
Dm Med City Hospitals (India) Private Limited
Premium access

Shareholding and investment profile for Abdul Salam Ameerali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Salam Ameerali

Abdul Salam Ameerali currently holds 12 directorships: Hindustan Pharma Distributors Private Limited (Director, since 20 Oct 2021, revenue ₹135 Cr (FY 2025)); Sri Sainatha Multispeciality Hospitals Private Limited (Director, since 08 Nov 2021, revenue ₹74.74 Cr (FY 2025)); Dm Med City Hospitals (India) Private Limited (Director, since 10 Sep 2021, revenue ₹55.22 Cr (FY 2023)); Aster Clinical Lab Llp (Designated Partner, since 03 Sep 2021, revenue ₹39.44 Cr (FY 2021)); Ambady Infrastructure Private Limited (Director, since 02 Sep 2021, revenue ₹71.1 Lakh (FY 2023)); and 7 more.

Abdul Salam Ameerali was first appointed on 21 May 2018 as Director at Emed Human Resources India Private Limited. The most recent appointment on record is 28 Jul 2025 at Aster Dm Super-Specialty Hospital (Yeswanthpur) Private Limited.

The 8 current companies of Abdul Salam Ameerali that report revenue have a combined latest revenue of ₹307 Cr: Hindustan Pharma Distributors Private Limited ₹135 Cr (FY 2025); Sri Sainatha Multispeciality Hospitals Private Limited ₹74.74 Cr (FY 2025); Dm Med City Hospitals (India) Private Limited ₹55.22 Cr (FY 2023); Aster Clinical Lab Llp ₹39.44 Cr (FY 2021); Ambady Infrastructure Private Limited ₹71.1 Lakh (FY 2023); and 3 more.

The current boards of Abdul Salam Ameerali's companies include Abdurahman Kartholiparamba (Hindustan Pharma Distributors Private Limited), Amit Kumar (Hindustan Pharma Distributors Private Limited), Kasim Kanikkudiyil Latheef (Hindustan Pharma Distributors Private Limited), Nerendranath Venkatachala (Hindustan Pharma Distributors Private Limited), Maheshwarappa Revakka Sunil Kumar (Sri Sainatha Multispeciality Hospitals Private Limited), Wilson Joseph Thadathil (Sri Sainatha Multispeciality Hospitals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available